“Arrowhead increases ownership in Calando's outstanding equity to 79%” plus 1 more |
| Arrowhead increases ownership in Calando's outstanding equity to 79% Posted: 19 Jan 2011 01:14 AM PST Arrowhead Research Corporation today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted approximately $8M of Calando debt to Arrowhead into equity. Arrowhead now owns approximately 79% of Calando's outstanding equity. |
| Arrowhead Increases Investment in RNAi Subsidiary Calando Pharmaceuticals Posted: 18 Jan 2011 04:12 AM PST PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Increases Investment in RNAi Subsidiary Calando Pharmaceuticals |
| You are subscribed to email updates from Content Keyword RSS To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment